Related Experiment Video
Updated: Jul 13, 2026
09:07
Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages
Published on: October 30, 2018
Current development of nonviral-mediated gene transfer
1College of Science and Technology, Temple University, Philadelphia, Penylvania 19122, USA. gromano@temple.edu
Drug News & Perspectives
|July 20, 2007
Summary
Nonviral gene transfer offers a safer, scalable alternative for gene therapy, particularly for immunotherapy. However, low efficiency and transient expression limit its use in treating genetic disorders.
Area of Science:
- Gene Therapy
- Molecular Biology
- Biotechnology
Background:
- Nonviral-mediated gene transfer is utilized in clinical trials for genetic disorders, cancer, and preclinical studies for infectious diseases.
- Key advantages include non-infectious origins, minimal toxicity, and large-scale production capabilities.
- Current limitations involve low in vivo transfection efficiency and transient transgene expression.
Purpose of the Study:
- To review the development and applications of nonviral vectors in gene transfer.
- To highlight the suitability of nonviral vectors for immunotherapy applications.
Main Methods:
- Review of existing literature on nonviral vector development and gene therapy applications.
- Analysis of preclinical and clinical trial data regarding nonviral gene transfer efficiency and expression.
Main Results:
- Nonviral vectors are advantageous for cancer and infectious disease immunotherapy due to transient expression potentially inducing durable immune responses.
- Challenges remain in achieving efficient and long-term transgene expression for treating chronic genetic conditions.
Conclusions:
- Nonviral gene transfer is most promising for immunotherapy where transient expression suffices.
- Further development is needed to overcome efficiency and duration limitations for treating genetic diseases.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
02:18Types of Genetic Transfer Between Organisms
Genetic transfer occurs when genetic information is passed from one organism to another. It occurs via two mechanisms: vertical gene transfer and horizontal gene transfer. Vertical gene transfer occurs when genetic information is transferred from one generation to the next, which happens much more frequently than horizontal gene transfer. Both sexual and asexual reproduction are forms of vertical gene transfer, where one or more organisms pass some or all of their genome onto their progeny.